<DOC>
	<DOCNO>NCT02789501</DOCNO>
	<brief_summary>Catheter infection dysfunction major cause morbidity mortality haemodialysis patient . According US Renal Data System , infection second lead cause death dialysis patient lead cause catheter removal morbidity patient end-stage renal disease . There evidence catheter lock solution contain taurolidine reduce risk catheter relate infection improve catheter patency . Lock solution local , systemic effect . In study taurolidine base lock regimen ( TauroLock™-Hep500 , Tauropharm , Waldbüttelbrunn , Germany , 2x/week TauroLock™-U25.000 , Tauropharm , Waldbüttelbrunn , Germany , 1x/ week ) compare 4 % citrate ( CitraFlow™ 4 % , MedXL , Montreal , Canada , 3x/week ) standard lock solution . The objective study evaluate TauroLock™ base regimen lock tunneled haemodialysis catheter reduce effect catheter relate blood stream infection catheter dysfunction .</brief_summary>
	<brief_title>Comparison TauroLock™ Based Regimen 4 % Citrate Lock Solution Tunneled Haemodialysis Catheters Prevention Bacteraemia Dysfunction</brief_title>
	<detailed_description />
	<mesh_term>Kidney Failure , Chronic</mesh_term>
	<mesh_term>Bacteremia</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Citric Acid</mesh_term>
	<mesh_term>Taurolidine</mesh_term>
	<criteria>Adult patient age great 18 year . Written informed consent . Requirement haemodialysis use tunneled dialysis catheter . Children age less 18 year . Positive blood culture previous seven day catheter insertion . Heparin induce thrombocytopenia contraindication anticoagulation ( recent plan surgery , thrombocytopenia &lt; 70G/l , bleed disorder ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Catheter</keyword>
	<keyword>Dysfunctions</keyword>
	<keyword>Blood Stream Infections</keyword>
	<keyword>Haemodialysis</keyword>
	<keyword>Taurolidine</keyword>
	<keyword>Tunneled</keyword>
</DOC>